Skip to main content

UPDATE: ProSanos and Management Science Associates Forge Alliance

This story has been updated from a previous version.

NEW YORK, June 21 – ProSanos and Management Science Associates have entered into a strategic relationship to develop and market biomedical informatics, the companies said Thursday. 

As part of the collaboration, MSA took an equity stake in ProSanos, Jonathan Morris, CEO of ProSanos, told GenomeWeb. Further financial details of the agreement were not disclosed. 

As a first step in this alliance, the companies have already built a joint data center to address security issues and biomedical data integrity standards. 

“MSA has a proven track record, not only with infrastructure but also with domain and security expertise that complements us,” said Morris. “They have all of the physical plant where we can host our high performance needs."

La Jolla, Calif.-based ProSanos, formerly called GenMatics, incorporates clinical outcomes information with molecular data in disease models. Management Science Associates of Pittsburgh, through its medical division, develops analytical software and data management to collect, annotate, analyze, and store clinical and molecular data.

Morris declined to offer additional information about his company.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.